View ValuationBrederode 将来の成長Future 基準チェック /06現在、 Brederodeの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Capital Markets 収益成長11.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBuy Or Sell Opportunity • Feb 25Now 21% overvaluedOver the last 90 days, the stock has fallen 1.5% to €105. The fair value is estimated to be €87.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 16%.お知らせ • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026お知らせ • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025Buy Or Sell Opportunity • Dec 05Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.5% to €104. The fair value is estimated to be €130, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Nov 12Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at €105. The fair value is estimated to be €132, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Oct 23Now 20% undervaluedOver the last 90 days, the stock has risen 1.8% to €110. The fair value is estimated to be €139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.6% to €112. The fair value is estimated to be €140, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.お知らせ • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024Buying Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.9%. The fair value is estimated to be €118, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Earnings per share has declined by 24%.New Risk • Aug 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risk Shareholders have been diluted in the past year (4.3% increase in shares outstanding).お知らせ • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €97.50, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 11x in the Capital Markets industry in Europe. Total returns to shareholders of 62% over the past three years.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Is New 90 Day High Low • Mar 11New 90-day high: €88.20The company is up 10.0% from its price of €80.50 on 11 December 2020. The Luxembourger market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 9.0% over the same period.Is New 90 Day High Low • Jan 23New 90-day high: €85.00The company is up 13% from its price of €75.00 on 23 October 2020. The Luxembourger market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Capital Markets industry, which is up 17% over the same period.Is New 90 Day High Low • Nov 27New 90-day high: €80.00The company is up 6.0% from its price of €75.30 on 28 August 2020. The Luxembourger market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 29New 90-day low: €71.80The company is down 4.0% from its price of €74.50 on 30 July 2020. The Luxembourger market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 5.0% over the same period.Is New 90 Day High Low • Sep 29New 90-day high: €78.50The company is up 5.0% from its price of €74.60 on 01 July 2020. The Luxembourger market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 1.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Brederode は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BDL:BREL - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2025891243636N/A9/30/202552873636N/A6/30/202514503636N/A3/31/20251962323636N/A12/31/20243774133737N/A9/30/20243063433737N/A6/30/20242362723737N/A3/31/20242202533131N/A12/31/20232052342626N/A9/30/20231711992626N/A6/30/20231371652626N/A3/31/202317463030N/A12/31/2022-103-733434N/A9/30/20221211513434N/A6/30/20223453753434N/A3/31/20226747053333N/A12/31/20211,0041,0363232N/A9/30/20219329643232N/A6/30/20218608923232N/A3/31/20215465773131N/A12/31/20202322623030N/A9/30/20201832132929N/A6/30/20201351652929N/A3/31/20202823112828N/A12/31/20194304582727N/A9/30/2019356384N/A27N/A6/30/2019282310N/A28N/A3/31/2019220246N/A27N/A12/31/2018157182N/A26N/A9/30/2018175200N/A26N/A6/30/2018193218N/A26N/A3/31/2018170194N/A24N/A12/31/2017147170N/A23N/A9/30/2017180203N/A23N/A6/30/2017214237N/A23N/A3/31/2017193204N/A11N/A12/31/2016172172N/A0N/A9/30/2016122122N/A-2N/A6/30/20167372N/A-3N/A3/31/2016151148N/A1N/A12/31/2015229224N/A4N/A9/30/2015252248N/A5N/A6/30/2015276272N/A6N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: BRELの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: BRELの収益がLuxembourg市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: BRELの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: BRELの収益がLuxembourg市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: BRELの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: BRELの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YDiversified-financials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 14:43終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Brederode SA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Buy Or Sell Opportunity • Feb 25Now 21% overvaluedOver the last 90 days, the stock has fallen 1.5% to €105. The fair value is estimated to be €87.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 16%.
お知らせ • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026
お知らせ • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025
Buy Or Sell Opportunity • Dec 05Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.5% to €104. The fair value is estimated to be €130, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Nov 12Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at €105. The fair value is estimated to be €132, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Oct 23Now 20% undervaluedOver the last 90 days, the stock has risen 1.8% to €110. The fair value is estimated to be €139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.6% to €112. The fair value is estimated to be €140, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
お知らせ • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024
Buying Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.9%. The fair value is estimated to be €118, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Earnings per share has declined by 24%.
New Risk • Aug 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risk Shareholders have been diluted in the past year (4.3% increase in shares outstanding).
お知らせ • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €97.50, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 11x in the Capital Markets industry in Europe. Total returns to shareholders of 62% over the past three years.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Is New 90 Day High Low • Mar 11New 90-day high: €88.20The company is up 10.0% from its price of €80.50 on 11 December 2020. The Luxembourger market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Jan 23New 90-day high: €85.00The company is up 13% from its price of €75.00 on 23 October 2020. The Luxembourger market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Capital Markets industry, which is up 17% over the same period.
Is New 90 Day High Low • Nov 27New 90-day high: €80.00The company is up 6.0% from its price of €75.30 on 28 August 2020. The Luxembourger market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 29New 90-day low: €71.80The company is down 4.0% from its price of €74.50 on 30 July 2020. The Luxembourger market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 5.0% over the same period.
Is New 90 Day High Low • Sep 29New 90-day high: €78.50The company is up 5.0% from its price of €74.60 on 01 July 2020. The Luxembourger market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 1.0% over the same period.